RxDoctor Payments Data

Anna Zampini, MD

Urology · Cleveland, OHNPI 1104169333

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,000 of the $35,957 with a category attached, or 69.5%. Boston Scientific accounts for 75.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $25,164 and has fallen 69.1% since, to $7,770 in 2025. Among urology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,957in general payments, 2019–2025

Across 36 payments — averaging $998.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$27K
  • Cook Incorporated$6K
  • Cook Medical LLC$1K
  • Calyxo, Inc.$483
  • Coloplast$322
  • C. R. Bard, Inc. & Subsidiaries$130
  • plus $348 from 4 others

What the payments were for

  • Consulting fees$1,5004%
  • Speaking & faculty fees$6,06017%
  • Grants$25,00070%
  • Travel & lodging$9023%
  • Food & beverage$2,4857%
  • Education$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,957 in reported general payments places this provider in the 90th percentile of 485 urology providers in Ohio.

See all urology providers in Ohio

Medicare billing

Part B allowed, 2024
$81,670
Medicare patients
185
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Citrate ErPotassium Citrate54$6,082
Tamsulosin Hcl96$800
Finasteride35$518
Gentamicin Sulfate45$350
Sodium Chloride0.9 % Sodium Chloride45$221
Oxybutynin Chloride ErOxybutynin Chloride11$166
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$126
Cephalexin22$122
Hydrochlorothiazide12$22

Paid to pharmacies, not to this prescriber.

Other urology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →